Copyright
©The Author(s) 2021.
World J Clin Cases. Dec 6, 2021; 9(34): 10400-10417
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10400
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10400
Table 1 circRNAs involved in gastric cancer gene transcription regulation and drug resistance
Cancer species | circRNA | Gene expression | Mechanism | Drug | Ref. | |
Up | Down | |||||
Gastric cancer | circRNA100876 | ↑ | Via miR-665/YAP1 signaling pathway | NR | [66] | |
Gastric cancer | circCUL3 | ↑ | Acts as a sponge for miR-515-5p | NR | [67] | |
Gastric cancer | circTMEM87A | ↑ | Acts as a sponge for miR-142-5p | NR | [68] | |
Gastric cancer | circRNA0044516 | ↑ | Acts as a sponge for miR-149 | NR | [69] | |
Gastric cancer | circ0000039 | ↑ | Acts as a sponge for miR-1292-5p | NR | [70] | |
Gastric cancer | has-circ-0004872 | ↓ | Acts as a sponge for miR-224 | NR | [71] | |
Gastric cancer | circ-ITCH | ↓ | Negative regulation of Wnt/β-catenin signaling pathway | NR | [72] | |
Gastric cancer | circPDZD8 | ↑ | Acts as a sponge for miR-197-5p | NR | [73] | |
Gastric cancer | circMTHFD2 | ↑ | Combined with miR-124 to exert sponge effect and induce MDR-1 protein | Pemetrexed | [74] | |
Gastric cancer | circ-PVT1 | ↑ | By negatively regulating miR-124-3p | Paclitaxel | [75] | |
Gastric cancer | circAKT3 | ↑ | Promote PIK3R1 expression through miR-198 | Cisplatin | [76] | |
Gastric cancer | circFhashsa-circ-0058147 | ↑ | Regulation of cisplatin activity via miR-182-5p | Cisplatin | [77] |
Table 2 circRNAs involved in liver cancer gene transcription regulation and drug resistance
Cancer type | circRNA | Gene expression | Mechanism | Drug | Ref. | |
Up | Down | |||||
Liver cancer | circ100084 | ↑ | Promotes IGF2 expression by acting as a sponge for HSA-MIR-23A-5P | NR | [81] | |
Liver cancer | circABCB10 | ↑ | Upregulates HMG20A expression by acting as a miR-670-3p sponge | NR | [83] | |
Liver cancer | circRNA-101237 | ↑ | Increased levels in serum and Huh7 cells of cisplatin-resistant HCC patients | Cisplatin | [84] | |
Liver cancer | Hsa-circ-u0006294, hsa-circ-u0035944, hsa-circ-u0084663 | ↓ | Plays a role by activating the Wnt/β-catenin pathway | Sorafenib | [85] | |
Liver cancer | circ-0003418 | ↓ | Inhibits Wnt/β-catenin pathway | Cisplatin | [86] | |
Liver cancer | circFBXO11 | ↑ | Uses miR-605 /FOXO3/ABCB1 axis adjustment | Oxaliplatin | [87] |
Table 3 circRNAs involved in colon cancer gene transcription regulation and drug resistance
Cancer type | circRNA | Gene expression | Mechanism | Drug | Ref. | |
Up | Down | |||||
Colon cancer | circNSUN2 | ↑ | Interact with YTHDC1, SRSF3 and NXF1 | NR | [91] | |
Colon cancer | hsa-circ-101555 | ↑ | Acts as miR-597-5p sponge | NR | [92] | |
Colon cancer | circHIPK3 | ↑ | Acts as miR-7 sponge | NR | [93] | |
Colon cancer | circCCDC66 | ↑ | DHX9 phosphorylation | Oxaliplatin | [94,95] | |
Colon cancer | circ-001680 | ↑ | Adjust BMI1 via miR-340 | Irinotecan | [98] | |
Colon cancer | hsa-circ-0005963 | ↑ | Acts as miR-122 sponge | Oxaliplatin | [99] | |
Colon cancer | circ-0000338 | ↑ or ↓ | Knock out circ-0000338 improves drug resistance | 5-FU | [100] | |
Colon cancer | hsa-circ-32883 | ↑ | uncertain | 5-FU, oxaliplatin | [101] | |
Colon cancer | circ0007031, circ0000504, circ0007006 | ↑ | Use hsa-miR485-5p pathway | 5-FU | [102] | |
Colon cancer | hsa-circ-0079662 | ↑ | Using the TNF-α pathway | oxaliplatin | [103] | |
Colon cancer | circDDX17 | ↑ | Adjustable via miR-31-5p/KANK1 axis | 5-FU | [104] |
Table 4 circRNAs involved in esophageal cancer gene transcription regulation and drug resistance
Cancer type | circRNA | Gene expression | Mechanism | Drug | Ref. | |
Up | Down | |||||
Esophageal cancer | circUBAP2 | ↑ | Acts as miR-422a sponge | NR | [108] | |
Esophageal cancer | hsa-circ-0006948 | ↑ | miR-490-3p to enhance HMGA2-induced EMT | NR | [109] | |
Esophageal cancer | circ-0000654 | ↑ | miR-149-5p/IL-6/STAT3 pathway | NR | [110] | |
Esophageal cancer | circGSK3 | ↑ | β-catenin signal passing | NR | [111] | |
Esophageal cancer | circ-Foxo3 | ↓ | miR-23a/PTEN pathway | NR | [112] | |
Esophageal cancer | circPVT1 | ↑ | Acts as miR-4663 sponge | NR | [113] | |
Esophageal cancer | ciRS-7 | ↑ | Acts as a miR-876-5p sponge | Rapamycin | [114,115] | |
Esophageal cancer | circRNA-001275 | ↑ | Acts as a miR-370-3p sponge | Cisplatin | [117] |
Table 5 circRNAs involved in pancreatic cancer gene transcription regulation and drug resistance
Cancer type | circRNA | Gene expression | Mechanism | Drug | Ref. | |
Up | Down | |||||
Pancreatic cancer | circBFAR | ↑ | Acts as a miR-34b-5p sponge | NR | [119] | |
Pancreatic cancer | circFOXK2 | ↑ | Acts as miR-942 sponge | NR | [120] | |
Pancreatic cancer | circ-ADAM9 | ↑ | Activate ERK/VEGF signaling pathway through miR-217 | NR | [121] | |
Pancreatic cancer | circ-ASH2L | ↑ | Acts as a sponge for miR-34a | NR | [122] | |
Pancreatic cancer | circ-LDLRAD3 | ↑ | Adjustable via miR-137-3p/PTN axis | NR | [123] | |
Pancreatic cancer | circ-0000977 | ↑ | Acts as a sponge for miR-153 | NR | [124] | |
Pancreatic cancer | hsa-circRNA-0007334 | ↑ | Competitive binding through hsa-miR-144-3p | NR | [125] | |
pancreatic cancer | ciRS-7 | ↑ | Acts as miR-7 sponge | NR | [126] | |
Pancreatic cancer | circ-0030235 | ↑ | Acts as miR-1253 and miR-1294 sponge | NR | [127] | |
Pancreatic cancer | circZMYM2 | ↑ | Acts as a miR-335-5p sponge | NR | [128] | |
Pancreatic cancer | circ-0007534 | ↑ | Acts as miR-625, miR-892b sponge | NR | [129] | |
Pancreatic cancer | circ-IARS | ↑ | Acts as miR-122 sponge | NR | [130] | |
Pancreatic cancer | circ-PDE8A | ↑ | As a sponge of miR-338 to regulate MACC1 | NR | [131] | |
Pancreatic cancer | circHIPK3 | ↑ | Acts as a miR-330-5p sponge | Gemcitabine | [133] |
- Citation: Xi SJ, Cai WQ, Wang QQ, Peng XC. Role of circular RNAs in gastrointestinal tumors and drug resistance. World J Clin Cases 2021; 9(34): 10400-10417
- URL: https://www.wjgnet.com/2307-8960/full/v9/i34/10400.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i34.10400